Flagship Labs 94, Inc. – Trademark Portfolio
Entity Type: 03
Flagship Labs 94, Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 1 trademark is registered and 2 are pending. Notable registered marks include EXPEDITION. The owner is based in Cambridge, MA.
55 Cambridge Parkway, Suite 800E
Cambridge, MA 02142
Showing of trademarks Trademarks
Trademark Classifications
Flagship Labs 94, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Flagship Labs 94, Inc. have?
Flagship Labs 94, Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 pending.
What trademark classes does Flagship Labs 94, Inc. file in?
Flagship Labs 94, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Flagship Labs 94, Inc.'s most well-known trademarks?
Flagship Labs 94, Inc.'s registered trademark portfolio includes well-known marks such as EXPEDITION. These are among 1 currently registered trademark in the portfolio.
What is Flagship Labs 94, Inc.'s trademark registration success rate?
Flagship Labs 94, Inc. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 2 applications are pending review.